3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
3
Genitourinary
3
Other solid neoplasm
2
Myeloid
2
Sarcoma
1
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Cytarabine
465
Cyclophosphamide
459
fludarabine phosphate
277
Rituximab
249
Methotrexate
245
Etoposide
203
fludarabine
200
Filgrastim
199
Peripheral Blood Stem Cell Transplantation
180
Busulfan
169
Vincristine
163
Dexamethasone
153
Daunorubicin
151
Azacitidine
145
Mycophenolic Acid
142
Whole-Body Irradiation
133
Tacrolimus
127
Imatinib Mesylate
127
Cyclosporine
123
Granulocyte Colony-Stimulating Factor
118
Radiotherapy
113
Melphalan
110
Idarubicin
103
Doxorubicin
101
Mitoxantrone
97
Antilymphocyte Serum
97
Lenalidomide
96
Decitabine
96
Mercaptopurine
93
Prednisone
91
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Molecular Diagnostic Techniques
×
Other hematologic neoplasm
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled